Press releases | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Press releases

PRESS RELEASE

published on 02/16/2026 at 08:00, 6 months 24 days ago

GABLER GROUP plans initial public offering to accelerate growth
Gabler Maschinenbau GmbH, an established developer and manufacturer of subsea technologies, plans an initial public offering (IPO) to accelerate growth. IPO intended to strengthen balance sheet, target net proceeds of EUR 40 million

IPO Initial Public Offering EUR 40 Million Subsea Technologies Gabler Maschinenbau GmbH
PRESS RELEASE

published on 02/16/2026 at 08:00, 6 months 24 days ago

Axiodis CRO accélère sa stratégie commerciale et marketing pour soutenir une croissance ambitieuse sous l'impulsion d'Oxurion
Axiodis CRO, filiale d'Oxurion, annonce l'intégration de nouveaux profils et une stratégie de croissance ambitieuse avec des partenariats stratégiques et l'utilisation de l'IA pour renforcer ses services en biométrie et data-cliniques

Croissance Partenariats Stratégiques IA Oxurion Axiodis CRO
PRESS RELEASE

published on 02/16/2026 at 08:00, 6 months 24 days ago

Axiodis CRO accelerates its sales and marketing strategy to support ambitious growth driven by Oxurion
Axiodis CRO, a subsidiary of Oxurion Group, announces key developments in its growth strategy: recruiting sales & marketing roles, overhauling website, enhancing marketing strategy & targeting European market

Growth Strategy European Market Clinical Data Management Axiodis CRO Oxurion Group
PRESS RELEASE

published on 02/16/2026 at 08:00, 6 months 24 days ago

Axiodis CRO versnelt zijn commerciële en marketingstrategie om ambitieuze groei onder impuls van Oxurion te ondersteunen
Axiodis CRO, Tochterunternehmen von Oxurion, stärkt Position auf dem europäischen Markt für klinische Datendienste durch Einstellung neuer Mitarbeiter und digitale Marketingstrategie

Oxurion Axiodis CRO Klinische Daten Europäischer Markt Digitales Marketing
PRESS RELEASE

published on 02/16/2026 at 08:00, 6 months 24 days ago

Capital B confirme l'acquisition de 6 BTC pour 0,3 M EUR , la détention d'un total de 2 834 BTC, et un 'BTC Yield' de 0,2% depuis le début de l'année
Capital B confirme l'acquisition de 6 BTC pour 0,3 M€ et détient 2 834 BTC, avec un 'BTC Yield' de 0,2%

Acquisition BTC Bitcoin Treasury Capital B €
PRESS RELEASE

published on 02/16/2026 at 08:00, 6 months 24 days ago

Capital B confirms the acquisition of 6 BTC for EUR 0.3 million, the holding of a total of 2,834 BTC, and a BTC Yield of 0.2% YTD
Capital B confirms acquisition of 6 BTC for €0.3 million, holding 2,834 BTC, BTC Yield at 0.2% YTD. Finalizes capital increase at €0.67 per share. Company expands BTC holdings

Capital Increase Bitcoin Treasury Company BTC Acquisition BTC Yield Capital B
PRESS RELEASE

published on 02/16/2026 at 07:30, 6 months 24 days ago

SUSS concludes new syndicated loan agreement
SUSS MicroTec SE secures €115 million syndicated loan agreement for corporate financing and refinancing, enhancing financial flexibility and liquidity. Consortium includes European banks

Refinancing SÜSS MicroTec SE Corporate Financing European Banks Syndicated Loan Agreement
PRESS RELEASE

published on 02/16/2026 at 07:30, 6 months 24 days ago

Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470
Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients

FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
PRESS RELEASE

published on 02/16/2026 at 07:30, 6 months 24 days ago

Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470
Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470, confirmant le dépôt de la NDA pour l'été 2026. Collaboration avec Kowa et avancée vers l'autorisation de mise sur le marché

FDA Nicox NCX 470 Réunion Pré-NDA Autorisation De Marché
PRESS RELEASE

published on 02/16/2026 at 07:00, 6 months 24 days ago

Romande Energie guiding for higher-than-expected 2025 financial results
Romande Energie anticipates exceeding 2025 financial expectations as per recent guidance. Check out the press release for more details

Ad Hoc Announcement Guidance Romande Energie 2025 Financial Results Higher-than-expected

Accesswire

Published on 09/12/2026 at 02:35, 9 hours 12 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 12 hours 47 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 13 hours 42 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 14 hours 22 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 18 hours 47 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 4 hours 17 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 13 hours 32 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 13 hours 37 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 16 hours 2 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 17 hours 32 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 4 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 4 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 4 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 4 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 16 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE